O

Obio Technology Shanghai Corp Ltd
SSE:688238

Watchlist Manager
Obio Technology Shanghai Corp Ltd
SSE:688238
Watchlist
Price: 5.73 CNY 0.7% Market Closed
Market Cap: 3.7B CNY
Have any thoughts about
Obio Technology Shanghai Corp Ltd?
Write Note

Obio Technology Shanghai Corp Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Obio Technology Shanghai Corp Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
O
Obio Technology Shanghai Corp Ltd
SSE:688238
Long-Term Investments
ÂĄ107.5m
CAGR 3-Years
85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Long-Term Investments
ÂĄ11.3B
CAGR 3-Years
3%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Long-Term Investments
ÂĄ968m
CAGR 3-Years
14%
CAGR 5-Years
33%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Long-Term Investments
ÂĄ2.8B
CAGR 3-Years
20%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Long-Term Investments
ÂĄ17.7B
CAGR 3-Years
29%
CAGR 5-Years
167%
CAGR 10-Years
81%
W
WuXi XDC Cayman Inc
HKEX:2268
Long-Term Investments
ÂĄ12.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Obio Technology Shanghai Corp Ltd
Glance View

Market Cap
3.7B CNY
Industry
Life Sciences Tools & Services

Obio Technology Shanghai Corp. Ltd. engages in biomedical basic research, gene therapy drug incubation, and clinical grade gene therapy virus vector CDMO service provision. The company is headquartered in Shanghai, Shanghai and currently employs 631 full-time employees. The company went IPO on 2022-03-22. The firm is mainly engaged in providing contract research organization (CRO) services such as gene therapy vector development and gene function research for the basic research of gene therapy, as well as contract research and development production organization (CDMO) services such as pharmaceutical research and clinical sample production for the research and development of gene drugs. The firm mainly conducts business in the European and American markets and the domestic market.

Intrinsic Value
4.49 CNY
Overvaluation 22%
Intrinsic Value
Price
O

See Also

What is Obio Technology Shanghai Corp Ltd's Long-Term Investments?
Long-Term Investments
107.5m CNY

Based on the financial report for Dec 31, 2023, Obio Technology Shanghai Corp Ltd's Long-Term Investments amounts to 107.5m CNY.

What is Obio Technology Shanghai Corp Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
85%

Over the last year, the Long-Term Investments growth was 154%. The average annual Long-Term Investments growth rates for Obio Technology Shanghai Corp Ltd have been 85% over the past three years .

Back to Top